4//SEC Filing
Marquet Magda 4
Accession 0001104659-24-072826
CIK 0001829635other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:16 PM ET
Size
5.6 KB
Accession
0001104659-24-072826
Insider Transaction Report
Form 4
Marquet Magda
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-14+70,000→ 70,000 totalExercise: $1.20Exp: 2034-06-13→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001631486
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:16 PM ET
- Size
- 5.6 KB